OPERATING AND REPORTABLE SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Segment Reporting Information

Segment Reporting Information

(in thousands)

	Three Months Ended   June 30,						Six Months Ended   June 30,
	2015			2014			2015			2014
Results of Operations:
Revenue:
Infusion Services - product revenue	$	241,020		$	225,277		$	480,067		$	441,180
Infusion Services - service revenue	5,957			5,271			11,187			10,437
Total Infusion Services revenue	246,977			230,548			491,254			451,617
PBM Services - service revenue	15,386			16,577			32,790			34,801
Total revenue	$	262,363		$	247,125		$	524,044		$	486,418
Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	4,140		$	16,194		$	16,839		$	31,155
PBM Services	1,737			1,837			3,126			3,512
Total Segment Adjusted EBITDA	5,877			18,031			19,965			34,667
Corporate overhead	(8,411		)	(7,016		)	(16,179		)	(14,492		)
Consolidated Adjusted EBITDA	(2,534		)	11,015			3,786			20,175
Interest expense, net	(9,080		)	(9,135		)	(18,243		)	(19,634		)
Loss on sale of assets	(628		)				(628		)	—
Income tax (expense) benefit	19,921			(3,063		)	17,993			(6,554		)
Depreciation	(4,130		)	(3,958		)	(8,434		)	(7,794		)
Amortization of intangibles	(1,489		)	(1,620		)	(2,979		)	(3,323		)
Impairment of goodwill	(238,000		)	—			(238,000		)	—
Stock-based compensation expense	(1,162		)	(1,998		)	(2,819		)	(4,884		)
Acquisition and integration expenses	(259		)	(5,333		)	(479		)	(11,832		)
Restructuring and other expenses	(5,803		)	(4,519		)	(9,266		)	(10,021		)
Loss from continuing operations, net of income taxes	$	(243,164	)	$	(18,611	)	$	(259,069	)	$	(43,867	)

Supplemental Operating Data
	June 30, 2015		December 31, 2014
Total Assets:
Infusion Services	$	510,566	$	755,955
PBM Services	26,702		29,147
Corporate unallocated, including cash and cash equivalents	39,881		39,611
Total Assets	$	577,149	$	824,713